a:head bio AG
PrivateLast Round
Early Funding
Apr 17, 2025
Total Funding Raised
$7.23M
Company Overview
a:head bio AG is a biotechnology company that develops novel therapeutics for the treatment of central nervous system disorders using a proprietary human cerebral organoid drug discovery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
a:head bio AG Comparables
Compare a:head bio AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Herophilus | 90% | |
| 28bio | 87% | |
| Synaxys | 86% | |
a:head bio AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 17, 2025 | ||||
| VC Round | Oct 9, 2024 | ||||
| Grant | Oct 25, 2019 | ||||
| Seed | Aug 7, 2019 |
a:head bio AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FFG Austrian Research Promotion Agency | Grant |
| red-stars.com data | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 3, 2026
Grew 54% QoQ, from 13 to 20 employees.
a:head bio AG Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about a:head bio AG's valuation, stock price, and market status.